Published in J Appl Physiol (1985) on July 01, 1988
Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins. Antimicrob Agents Chemother (1992) 0.92
The yeast homolog of heme oxygenase-1 affords cellular antioxidant protection via the transcriptional regulation of known antioxidant genes. J Biol Chem (2010) 0.84
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest (2000) 5.26
Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med (2001) 3.92
Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol (1994) 3.83
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J (2001) 3.20
Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J (2005) 2.82
Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol (2000) 2.73
Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest (1998) 2.54
Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest (1998) 2.37
Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest (1995) 2.30
Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest (1997) 2.29
Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol (2001) 2.24
Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur J Clin Pharmacol (2000) 2.24
Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med (1999) 2.21
Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis. Circ Res (2001) 2.00
Compartmentation of glutathione: implications for the study of toxicity and disease. Toxicol Appl Pharmacol (1996) 2.00
Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest (1987) 1.96
Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. J Pharmacol Exp Ther (1983) 1.79
Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res (2001) 1.75
Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol (1999) 1.63
Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis (1990) 1.62
Hypoxia inducible factor-1α in human emphysema lung tissue. Eur Respir J (2010) 1.62
Proactive integrated care improves quality of life in patients with COPD. Eur Respir J (2009) 1.61
Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. J Clin Invest (1999) 1.59
Nonimmunological production of leukotrienes induced by platelet-activating factor. Science (1982) 1.58
In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol (1998) 1.54
Hypothyroidism and primary pulmonary hypertension: an autoimmune pathogenetic link? Ann Intern Med (1993) 1.51
Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration. Eur J Clin Pharmacol (1989) 1.50
Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. Science (1987) 1.47
Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol (1997) 1.46
Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia. J Appl Physiol (1985) (2001) 1.44
Expiratory measurement of maximal amino-pyrine demethylation in vivo: effect of phenobarbital, partial hepatectomy, protacaval shunt and bile duct ligation in the rat. J Pharmacol Exp Ther (1976) 1.41
Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300 m. J Appl Physiol (1985) (1987) 1.40
Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest (1983) 1.31
HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. Am J Pathol (2001) 1.29
The systemic availability of oral glutathione. Eur J Clin Pharmacol (1992) 1.29
The pathobiology of pulmonary hypertension. Endothelium. Clin Chest Med (2001) 1.27
Pulmonary hypertension and inflammation. J Lab Clin Med (1998) 1.25
The pressure-overloaded right ventricle in pulmonary hypertension. Chest (1998) 1.24
Hepatic glutathione homeostasis in the rat: efflux accounts for glutathione turnover. Hepatology (1984) 1.23
5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension. Am J Respir Crit Care Med (1998) 1.18
Biliary excretion of glutathione and glutathione disulfide in the rat. Regulation and response to oxidative stress. J Clin Invest (1984) 1.18
Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling. Am J Respir Crit Care Med (2001) 1.16
Kava hepatotoxicity. Ann Intern Med (2001) 1.13
Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP. Am J Respir Cell Mol Biol (1997) 1.13
Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology (1995) 1.13
Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension. N Engl J Med (1983) 1.11
PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats. J Appl Physiol (1985) (1992) 1.10
Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS (1992) 1.10
Stimulation of respiration by methylene blue in rat liver mitochondria. FEBS Lett (1997) 1.10
Measurement of peptidoleukotrienes in biological fluids. J Appl Physiol (1985) (1990) 1.08
Vasopressin-induced pulmonary vasodilation in rats. Am J Physiol (1989) 1.07
Regulation of hepatic glutathione turnover in rats in vivo and evidence for kinetic homogeneity of the hepatic glutathione pool. J Clin Invest (1981) 1.07
Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension. Am J Physiol (1985) 1.06
Therapeutic doses of acetaminophen stimulate the turnover of cysteine and glutathione in man. J Hepatol (1987) 1.06
Analysis of 6-keto PGF1 alpha, 5-HETE, and LTC4 in rat lung: comparison of GM/MS, RIA, and EIA. Prostaglandins (1986) 1.03
Altered bile acid metabolism in primary biliary cirrhosis. Dig Dis Sci (1981) 1.03
High-dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urine. Eur J Clin Invest (1991) 1.01
The effects of age and glutathione depletion on hepatic glutathione turnover in vivo determined by acetaminophen probe analysis. J Pharmacol Exp Ther (1980) 1.00
Monoclonal endothelial cells in appetite suppressant-associated pulmonary hypertension. Am J Respir Crit Care Med (1998) 1.00
Leukotoxin, 9,10-epoxy-12-octadecenoate causes edematous lung injury via activation of vascular nitric oxide synthase. Am J Physiol (1995) 1.00
Release of vasodilator prostaglandin, PGI2, from isolated rat lung during vasoconstriction. Circ Res (1981) 0.97
Ethanol suppresses hepatic glutathione synthesis in rats in vivo. J Pharmacol Exp Ther (1984) 0.96
Clinical value of the bile acid breath test. Evaluation of the Mayo Clinic experience. Mayo Clin Proc (1978) 0.96
Decreased pulmonary vasoreactivity in an animal model of chronic Pseudomonas pneumonia. Am Rev Respir Dis (1990) 0.93
Hepatic functional deterioration after portacaval shunt in the rat. Effects on sulfobromophthalein transport-maximum, indocyanine green clearance and galactose elimination capacity. Gastroenterology (1976) 0.93
PAF antagonists: different effects on platelets, neutrophils, guinea pig ileum and PAF-induced vasodilation in isolated rat lung. Prostaglandins (1986) 0.92
Hyperuricemia in severe pulmonary hypertension. Chest (2000) 0.92
Effects of hypoxia on density of beta-adrenergic receptors. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.92
Cellular adaptation during chronic neonatal hypoxic pulmonary hypertension. Am J Physiol (1991) 0.92
Decreased production of glutathione in patients with cirrhosis. Eur J Clin Invest (1987) 0.92
Quantitative liver function in patients with rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study. Br J Rheumatol (1997) 0.92
Decreased release of glutathione into the systemic circulation of patients with HIV infection. Eur J Clin Invest (1996) 0.92
Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension. Am J Respir Cell Mol Biol (1989) 0.91
Importance of angiotensin-converting enzyme in pulmonary hypertension. Cardiology (1995) 0.91
Toxic doses of acetaminophen suppress hepatic glutathione synthesis in rats. Hepatology (1982) 0.91
Altering hydrodynamic variables influences PGI2 production by isolated lungs and endothelial cells. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.91
Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats. Eur Respir J (2009) 0.91
Vascular remodeling in neonatal pulmonary hypertension. Role of the smooth muscle cell. Chest (1988) 0.91
Endotoxin-induced lung injury in rats: role of eicosanoids. J Appl Physiol (1985) (1989) 0.91
Rapid onset of hypoxic vasoconstriction in isolated lungs. J Appl Physiol (1985) (1992) 0.90
Oxidant stress and hepatic necrosis in rats treated with diquat. J Pharmacol Exp Ther (1985) 0.90
Glutathione metabolism in activated human neutrophils: stimulation of glutathione synthesis and consumption of glutathione by reactive oxygen species. Eur J Clin Invest (1991) 0.90
Primary pulmonary hypertension, Castleman's disease and human herpesvirus-8. Eur Respir J (2003) 0.90
Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans. J Pharmacol Exp Ther (1985) 0.90
Divergent effects of intravenous GSH and cysteine on renal and hepatic GSH. Am J Physiol (1992) 0.89
Inflammatory cells and eicosanoid mediators in subjects with late asthmatic responses and increases in airway responsiveness. J Allergy Clin Immunol (1992) 0.89
Leukotoxin, 9,10-epoxy-12-octadecenoate causes pulmonary vasodilation in rats. Am J Physiol (1995) 0.89
Reperfusion injury of the liver: role of mitochondria and protection by glutathione ester. J Surg Res (1999) 0.89
Oxidation of mitochondrial proteins and DNA following administration of ethanol. Biochem Biophys Res Commun (1995) 0.88
Ventilatory responses of hamsters and rats to hypoxia and hypercapnia. J Appl Physiol (1985) (1985) 0.88
Effects of shear stress on adhesive interaction between neutrophils and cultured endothelial cells. J Appl Physiol (1985) (1987) 0.88
Pulmonary vascular injury by polycations in perfused rat lungs. J Appl Physiol (1985) (1987) 0.87
Effects of hypochlorous acid and chloramines on vascular resistance, cell integrity, and biliary glutathione disulfide in the perfused rat liver: modulation by glutathione. J Hepatol (1991) 0.87
Plexiform lesion in severe pulmonary hypertension: association with glomeruloid lesion. Am J Pathol (2001) 0.87
Effects of acute and chronic hypoxia on rat lung cyclooxygenase. Am J Physiol (1996) 0.87
Leukotriene synthesis and receptor blockers block hypoxic pulmonary vasoconstriction. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.86
Inactivation of leukotriene C4 in the airways and subsequent urinary leukotriene E4 excretion in normal and asthmatic subjects. Am Rev Respir Dis (1993) 0.86
Oxidation of hydrazine metabolites formed from isoniazid. Clin Pharmacol Ther (1985) 0.86
Insulin-like growth factor I and protein kinase C activation stimulate pulmonary artery smooth muscle cell proliferation through separate but synergistic pathways. J Cell Physiol (1990) 0.86
Endothelin-1 potentiates leukotoxin-induced edematous lung injury. J Appl Physiol (1985) (1995) 0.85